Table 1

BM and WAT cellularity in mice repopulated with WAT-KLS or BM-KLS

Total cell no., ×106
Percentage of CD45+ cells, % of total cells
Percentage of CD45.1+ cells, % of CD45+ cells
Absolute no. of KLS cells, ×104
BMWATBMWATBMWATBMWAT
WAT-KLS–repopulated mice 9.69 ± 1.71 1.36 ± 0.14 84.86 ± 1.80 64.66 ± 4.27 0.94 ± 0.2 33.6 ± 4.8 2.5 ± 0.4 2.4 ± 0.6 
BM-KLS–repopulated mice 7.16 ± 1.03 1.32 ± 0.24 84.39 ± 1.66 43.98 ± 5.39* 24 ± 6.6 30.75 ± 5.7 2.1 ± 0.7 0.48 ± 0.01 
Total cell no., ×106
Percentage of CD45+ cells, % of total cells
Percentage of CD45.1+ cells, % of CD45+ cells
Absolute no. of KLS cells, ×104
BMWATBMWATBMWATBMWAT
WAT-KLS–repopulated mice 9.69 ± 1.71 1.36 ± 0.14 84.86 ± 1.80 64.66 ± 4.27 0.94 ± 0.2 33.6 ± 4.8 2.5 ± 0.4 2.4 ± 0.6 
BM-KLS–repopulated mice 7.16 ± 1.03 1.32 ± 0.24 84.39 ± 1.66 43.98 ± 5.39* 24 ± 6.6 30.75 ± 5.7 2.1 ± 0.7 0.48 ± 0.01 

Lethally irradiated CD45.2 mice were intravenously injected with 103 CD45.1 WAT-KLS or BM-KLS cells together with 2.105 CD45.2 total BM cells. Four months after injection, BM and WAT were removed and total BM and SVF cells were prepared as described in “Isolation of WAT, spleen, thymus, ganglion, and BM cells.” The total cell number was quantified by cell counting and CD45+ and KLS cell numbers were estimated by flow cytometry. Results are expressed as means ± SEM of 7 independent experiments.

*

P < .001.

P < .0001 in WAT-KLS– versus BM-KLS–repopulated mice.

P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal